Items where authors include "Smyth, E"

Article

Lutz, MP, Zalcberg, JR, Ducreux, M et al. (21 more authors) (2019) The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma. European Journal of Cancer, 112. pp. 1-8. ISSN 0959-8049

Davarzani, N, Hutchins, GGA orcid.org/0000-0002-1707-4415, West, NP orcid.org/0000-0002-0346-6709 et al. (8 more authors) (2018) Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trial. Histopathology, 72 (7). pp. 1180-1188. ISSN 0309-0167

Smyth, E, Rowley, S, Allum, W et al. (17 more authors) (2016) A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948). Annals of Oncology, 27 (suppl_6). LBA26. ISSN 0923-7534

Proceedings Paper

Hutchins, GGA orcid.org/0000-0002-1707-4415, Davarzani, N, West, NP orcid.org/0000-0002-0346-6709 et al. (8 more authors) (2018) Defining the Clinical Value of Pathological Lymph Node Status and Primary Tumour Regression Grading Following Neoadjuvant Therapy in Oesophageal Cancer: Results from the MRC OE02 Trial. In: Journal of Pathology. Maastricht Pathology 2018: 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19-22 Jun 2018, Maastricht, the Netherlands. Wiley , S16-S16.